As was found in this study, galectin-3 is expressed in normal thyroid [74] and the higher levels in thyroid cancers, as seen in the present study, may be used to separate benign and malignant thyroid tissues provided appropriate evidence-based data are taken into consideration [75]. Here, LGALS3 is linked to thyroid gland carcinoma.